ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,094Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 546

$601K Total Retail Price of All Prescriptions

Rank: 35 out of 546

425 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 425 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

14% of this provider’s 425 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 8,708 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
SIMVASTATIN 523 424 1 2
LEVOTHYROXINE SODIUM 434 353 2 3
OMEPRAZOLE 412 337 3 4
FUROSEMIDE 395 335 4 5
METOPROLOL TARTRATE 306 240 5 6
LISINOPRIL 285 225 6 1
ATENOLOL 276 239 7 12
METFORMIN HCL 268 230 8 10
HYDROCODONE-ACETAMINOPHEN 262 183 S3 9 8
ATORVASTATIN CALCIUM 249 206 10 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 244 218 11 49
GABAPENTIN 225 168 12 16
LOVASTATIN 181 169 13 22
PANTOPRAZOLE SODIUM 168 106 14 18
SERTRALINE HCL 167 127 15 14
CITALOPRAM HBR 156 144 16 21
RANITIDINE HCL 156 126 16 23
HYDROCHLOROTHIAZIDE 150 138 18 7
OXYCODONE HCL 130 37 S2 19 15
GLIPIZIDE 128 108 20 44
METOPROLOL SUCCINATE 126 106 21 17
WARFARIN SODIUM 118 74 22 13
PREDNISONE 114 110 23 29
PROAIR HFA 113 63 24 27
TRAMADOL HCL 102 61 25 19
AMLODIPINE BESYLATE 102 76 25 9
CARBIDOPA-LEVODOPA 100 75 27 76
TRAZODONE HCL 96 63 28 25
ALENDRONATE SODIUM 95 84 29 38
ZOLPIDEM TARTRATE 91 69 30 26
CYCLOBENZAPRINE HCL 88 14 R 31 34
ATENOLOL-CHLORTHALIDONE 87 73 32 170
LOSARTAN POTASSIUM 85 73 33 24
ISOSORBIDE MONONITRATE ER 82 70 34 32
ADVAIR DISKUS 82 76 34 20
EVISTA 74 59 36 158
GLYBURIDE 73 57 R 37 45
JANTOVEN 73 70 37 92
ESCITALOPRAM OXALATE 70 68 39 66
SPIRIVA 70 70 39 28
CRESTOR 68 60 41 36
PRAVASTATIN SODIUM 67 64 42 33
LIPITOR 65 51 43 80
DIGOXIN 65 61 43 62
COMBIVENT 64 54 45 71
FLUTICASONE PROPIONATE 62 49 46 42
LIDODERM 61 50 47 73
VENTOLIN HFA 61 48 47 63
FLOVENT HFA 58 58 49 139
GLIPIZIDE ER 57 56 50 126
DOXAZOSIN MESYLATE 53 53 51 98
FENOFIBRATE 52 44 52 87
SPIRONOLACTONE 51 37 53 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 11, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.